These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5596865)

  • 21. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 24. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB; Eichelman B; Ng LK
    Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
    [No Abstract]   [Full Text] [Related]  

  • 25. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 26. Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.
    Brodie BB; Costa E; Dlabac A; Neff NH; Smookler HH
    J Pharmacol Exp Ther; 1966 Dec; 154(3):493-8. PubMed ID: 5928249
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of noradrenaline synthesis inhibition on motor activity and lever pressing for food and water in the rat.
    Beaton JM; Crow TJ
    Life Sci; 1969 Oct; 8(19):1129-34. PubMed ID: 5351026
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of rat brain tryptophan hydroxylase by 6-halotryptophans.
    McGeer EG; Peters DA; McGeer PL
    Life Sci; 1968 Jun; 7(12):605-15. PubMed ID: 5672661
    [No Abstract]   [Full Text] [Related]  

  • 31. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 32. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 33. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 34. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 35. The combined use of alpha-methyltyrosine and threo-dihydroxyphenylserine--selective reduction of dopamine levels in the central nervous system.
    Creveling CR; Daly J; Tokuyama T; Witkop B
    Biochem Pharmacol; 1968 Jan; 17(1):65-70. PubMed ID: 5638559
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of dopamine- -hydroxylase and tyrosine hydroxylase in rat hearts and sympathetic ganglia.
    Molinoff PB; Brimijoin S; Axelrod J
    J Pharmacol Exp Ther; 1972 Jul; 182(1):116-29. PubMed ID: 5041648
    [No Abstract]   [Full Text] [Related]  

  • 37. Some biochemical and pharmacological actions of -methylphenylalanine.
    Torchiana ML; Porter CC; Stone CA; Hanson HM
    Biochem Pharmacol; 1970 May; 19(5):1601-14. PubMed ID: 4998458
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic oral treatment with disulfiram on dopamine-beta-hydroxylase and biogenic amines.
    Lippmann W
    Eur J Pharmacol; 1968 Apr; 3(1):84-6. PubMed ID: 5654674
    [No Abstract]   [Full Text] [Related]  

  • 39. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 40. Catecholamines and the hydroxylation of tyrosine in synaptosomes isolated from rat brain.
    Karobath M
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2370-3. PubMed ID: 4400211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.